Morgan Stanley Rates Healthpeak Properties (DOC) hold

Morgan Stanley has adjusted its rating for Healthpeak Properties, Inc. to hold, with a price target of $22.00, a 9.51% upside from the current price.

By EarningsIQ Research Desk · Published Jun 14, 2026, 2:00 AM EDT · Updated Jun 17, 2026, 9:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Morgan Stanley rated Healthpeak Properties, Inc. ($DOC) "hold" with a $22 price target on June 11, 2026.

Since the rating, $DOC is down 4.1% after 1 week, up 6.5% after 1 month and down 5.6% to date (from the $20.11 close on Jun 11, 2026).

DOC Healthpeak Properties, Inc.

$18.98 +23.01% year to date

Daily close · Oct 16, 2026

Key Points

On June 11, 2026, Morgan Stanley lowered its rating on Healthpeak Properties, Inc. (DOC) to hold from overweight, setting a target price of $22.00.
Healthpeak Properties is currently trading at $20.09, near its 52-week high of $22.95, which suggests some caution among analysts.
The average target price from analysts for Healthpeak is $22.95, indicating a potential upside from the current trading price.

Get $DOC trade alerts by text

We text you when insiders, Congress or big funds trade $DOC. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Healthpeak Properties, Inc. alert may contain errors. Disclosures

Rating Change from Morgan Stanley

Morgan Stanley has lowered its rating on Healthpeak Properties, Inc. (DOC) to hold from overweight. The firm set a new price target of $22.00 on June 11, 2026. This adjustment comes as the stock is trading at $20.09, which reflects a cautious outlook on the company’s performance.

Analysts Set New Price Targets

Despite Morgan Stanley's downgrade, other analysts have maintained their ratings. UBS kept its Neutral rating with a target of $20.00, down from $21.50, while Barclays also maintained its Equal-Weight rating at $21.00, down from $24.00. Evercore ISI Group has a target of $22.00, slightly reduced from $23.00. Overall, the average target price from 19 analysts is $22.95, suggesting room for growth despite the recent rating change.

How Healthpeak Properties, Inc. Stock Has Traded

Healthpeak Properties is currently trading at $20.09, which is close to its 52-week high of $22.95. The stock has fluctuated between $15.70 and $22.95 over the past year. This relatively stable performance indicates investor confidence, although recent analyst actions reflect some caution.

12-month forecast

$DOC price target

Healthpeak Properties, Inc. daily closes and this analyst's $22 target. Not advice.

What Healthpeak Properties, Inc. Does

Healthpeak Properties, Inc. is a real estate investment trust (REIT) that focuses on high-quality real estate for healthcare-related uses. The company operates and develops properties that cater to healthcare discovery and delivery. This recent downgrade by Morgan Stanley highlights the ongoing scrutiny of its stock performance in a competitive market.

What’s Next for Healthpeak?

Investors will be watching for Healthpeak's next earnings report, scheduled for October 22, 2026. The recent rating change from Morgan Stanley is based on the company’s performance as of June 11, 2026, and may not represent its current status. As always, it’s important to keep an eye on future analyst ratings and market conditions.